Comparing night-time and full-time splinting for carpal tunnel syndrome
Official title: Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome: a Multi-center, Three-period, Randomized Cross-over Superiority Trial (FINCROSS - Finnish Crossover Trial for Carpal Tunnel Syndrome)
Run by Tampere University Hospital · NCT05637294 · Data updated 2026-11-12
This study is testing whether wearing a splint at night or all day helps people with carpal tunnel syndrome feel better and if it can reduce the need for surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 6 sites (Helsinki and 5 other locations) |
| Status | Recruiting |
| Started | February 15, 2023 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05637294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with clinically confirmed carpal tunnel syndrome symptoms lasting at least three weeks.
✕Probably not a fit
Patients with other neurological conditions or those who have had recent corticosteroid injections or surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of night-time versus full-time splinting for individuals with carpal tunnel syndrome, a condition characterized by pain and numbness in the hands. Participants will be randomly assigned to three treatment phases: night-time splinting, full-time splinting, and a control period with no treatment. The study aims to identify which patients benefit most from splinting and whether effective splinting can reduce the need for surgical intervention. A total of 110 participants will be recruited in Finland for this cross-over trial.
Why it matters
Potential benefit: If successful, this study could provide clearer guidelines on the most effective splinting methods for treating carpal tunnel syndrome, potentially reducing the need for surgery.
How similar studies have gone: Previous studies on splinting for carpal tunnel syndrome have shown varying degrees of success, making this approach both relevant and necessary for further exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinically confirmed carpal tunnel syndrome (CTS) of any severity level (diagnostic criteria: numbness, pain or paraesthesia in the median nerve distribution area of wrist and fingers), 2. Symptom duration of CTS for at least 3 weeks, 3. No previous corticosteroid injection for CTS during last 6 months, 4. No previous surgery for CTS, 5. Aged 18 years or older, 6. Able to complete self-report questionnaires electronically, 7. Able to understand Finnish, 8. Willing to join the study and follow the study protocol instructions, 9. Sign informed consent. Exclusion Criteria: 1. Nerve root or plexus disorders that might be causing CTS mimicking symptoms (e.g., cervical radiculopathy, thoracic outlet syndrome, or whiplash associated disorders), 2. Other neurological condition affecting the function of the hand such as Multiple Sclerosis, previous nerve injury, 3. Active Rheumatoid arthritis or any other active inflammatory joint disease affecting the hand, 4. Thenar muscle atrophy, 5. Untreated hypothyroidism, 6. Known allergy to any of the splint materials (self-reported by patient), 7. Long term treatment (over 4 months) for CTS with no response, 8. Any other known reason that could prevent from participation for the study time.
Where it's running
-
Terveystalo Kamppi
Helsinki, Finland Recruiting -
Hospital Nova of Central Finland
Jyväskylä, Finland Recruiting -
Terveystalo Jyväskylä
Jyväskylä, Finland Recruiting -
Mikkeli Central Hospital
Mikkeli, Finland Recruiting -
Terveystalo Tampere
Tampere, Finland Recruiting -
Tampere University Hospital
Tampere, Finland Active not recruiting
Study contacts
- Principal investigator: Teemu Karjalainen — Tampere University Hospital
- Study coordinator: Vieda Lusa
- Email: fincross.trial@gmail.com
- Phone: +358408713465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Matrix Rhythm Therapy for Carpal Tunnel Syndrome
This study tests whether adding Matrix Rhythm Therapy to standard care helps people with mild-to-moderate carpal tunnel syndrome improve symptoms, hand function, grip and pinch strength, and quality of life.
-
Carpal tunnel release vs placebo surgery in Finland
In this trial, people with carpal tunnel syndrome are randomly assigned to either standard carpal tunnel surgery or a pretend surgery to see if relief comes from the operation itself or from placebo effects.
-
High-intensity laser therapy for carpal tunnel syndrome
This trial will test whether high-intensity laser therapy helps adults 18–65 with mild-to-moderate carpal tunnel syndrome reduce pain and improve nerve function and hand strength compared with a sham procedure.
-
Ultrasound-guided needle release plus dextrose (D5W) hydrodissection for carpal tunnel syndrome
This trial tests whether combining ultrasound-guided partial release of the transverse carpal ligament with dextrose (D5W) hydrodissection provides better symptom relief for adults with carpal tunnel syndrome and at least moderate symptoms.
-
A mix of vitamins to help recovery after carpal tunnel surgery
This will test whether taking alpha-lipoic acid, vitamin E, and B vitamins helps adults recover better after carpal tunnel release surgery.
-
Symptom spread and pain sensitivity in carpal tunnel syndrome
This test looks at whether people with carpal tunnel syndrome whose symptoms spread beyond the usual finger area have higher central pain sensitivity, using a questionnaire and pressure pain testing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.